Nuzenio

Talazoparib

Talazoparib news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 5 publisher sources 100/100 entity strength

Latest news

TALAPRO-3 Results and the Role of Upfront PARP Inhibition in APMS Prostate Cancer - Andrew Armstrong - UroTodayUroToday · Fri, 07 Aug 2026 19:52:20 GMT HRR-Altered Metastatic Prostate Cancer Talazoparib Plus Enzalutamide Improves Progression-Free Survival - The ASCO PostThe ASCO Post · Thu, 06 Aug 2026 14:00:43 GMT Talazoparib and Enzalutamide Combo Shows Promise in Treating Certain Prostate Cancers - Oncology News CentralOncology News Central · Mon, 03 Aug 2026 00:00:00 GMT Metastatic HRR-altered hormone-sensitive prostate cancer: add talazoparib to enzalutamide - Vera HealthVera Health · Thu, 30 Jul 2026 03:53:13 GMT Biguanide derivative 4C boosts talazoparib by triggering ferroptosis in bladder cancer - Bioengineer.orgBioengineer.org · Tue, 28 Jul 2026 15:43:54 GMT

Timeline

Fri, 07 Aug 2026 19:52:20 GMTTALAPRO-3 Results and the Role of Upfront PARP Inhibition in APMS Prostate Cancer - Andrew Armstrong - UroToday

Thu, 06 Aug 2026 14:00:43 GMTHRR-Altered Metastatic Prostate Cancer Talazoparib Plus Enzalutamide Improves Progression-Free Survival - The ASCO Post

Mon, 03 Aug 2026 00:00:00 GMTTalazoparib and Enzalutamide Combo Shows Promise in Treating Certain Prostate Cancers - Oncology News Central

Thu, 30 Jul 2026 03:53:13 GMTMetastatic HRR-altered hormone-sensitive prostate cancer: add talazoparib to enzalutamide - Vera Health

Tue, 28 Jul 2026 15:43:54 GMTBiguanide derivative 4C boosts talazoparib by triggering ferroptosis in bladder cancer - Bioengineer.org

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

HRR3 live mentions Bioengineer3 live mentions Results2 live mentions Role2 live mentions Upfront PARP Inhibition2 live mentions APMS Prostate Cancer2 live mentions Altered Metastatic Prostate2 live mentions Cancer Talazoparib Plus2 live mentions Enzalutamide Improves Progression2 live mentions Enzalutamide Combo Shows2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Talazoparib.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.